Related Experiment Videos
Current status of endoscopic therapy for ulcer bleeding
1Hospital Privado, Catholic University School of Medicine, Cordoba, Cordoba, Argentina.
Bailliere'S Best Practice & Research. Clinical Gastroenterology
|August 23, 2000
Summary
Endoscopic hemostasis effectively treats peptic ulcer bleeding. Both single therapies (injection, thermal) and combination treatments show comparable efficacy, with operator experience influencing outcomes.
Area of Science:
- Gastroenterology
- Endoscopic interventions
Background:
- Peptic ulcer bleeding is a significant clinical challenge.
- Endoscopic hemostasis is a primary treatment modality.
- Previous meta-analyses established benefits of endoscopic hemostasis up to 1992.
Purpose of the Study:
- To review therapeutic endoscopic modalities for peptic ulcer bleeding.
- To emphasize randomized, prospective comparative trials from the last 20 years.
- To apply an evidence-based medicine approach to analyze efficacy.
Main Methods:
- Review of randomized, prospective comparative trials.
- Analysis of meta-analyses results.
- Translation of data into efficacy measures (relative risk reduction, absolute risk reduction, number needed to treat).
Main Results:
- Single-modality treatments (injection agents like epinephrine, sclerosants, thrombogenic substances; thermal therapies) are efficacious and comparable.
- Combination therapy (injection + thermal) may offer advantages over single-modality therapy.
- Variations in outcomes are likely due to operator experience and technique, not inherent inconsistency.
Conclusions:
- Therapeutic endoscopy offers effective options for peptic ulcer bleeding.
- Both single and combination endoscopic therapies are viable.
- Standardization of technique and operator experience are crucial for optimal results.